-+ 0.00%
-+ 0.00%
-+ 0.00%

Satellos Bioscience Q3 EPS $(0.53) Beats $(0.56) Estimate

Benzinga·11/12/2026 12:20:10
Listen to the news
Satellos Bioscience (NASDAQ:MSLE) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.56) by 5.36 percent. This is a 35.9 percent decrease over losses of $(0.39) per share from the same period last year.